AAAAAA
Results:
1-10
|
Results: 10
Authors:
Kattan, MW
Potters, L
Blasko, JC
Beyer, DC
Fearn, P
Cavanagh, W
Leibel, S
Scardino, PT
Citation: Mw. Kattan et al., Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer, UROLOGY, 58(3), 2001, pp. 393-399
Authors:
Rosenzweig, KE
Mychalczak, B
Fuks, Z
Hanley, J
Burman, C
Ling, CC
Armstrong, J
Ginsberg, R
Kris, MG
Raben, A
Leibel, S
Citation: Ke. Rosenzweig et al., Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer, CANCER J, 6(2), 2000, pp. 82-87
Authors:
Potters, L
Cha, C
Ashley, R
Freeman, K
Waldbaum, R
Wang, XH
Leibel, S
Citation: L. Potters et al., The role of external beam irradiation in patients undergoing prostate brachytherapy, UROL ONCOL, 5(3), 2000, pp. 112-117
Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy
Authors:
Potters, L
Torre, T
Ashley, R
Leibel, S
Citation: L. Potters et al., Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy, J CL ONCOL, 18(6), 2000, pp. 1187-1192
Authors:
Kattan, MW
Fearn, PA
Leibel, S
Potters, L
Citation: Mw. Kattan et al., The definition of biochemical failure in patients treated with definitive radiotherapy, INT J RAD O, 48(5), 2000, pp. 1469-1474
Authors:
Ling, CC
Humm, J
Larson, S
Amols, H
Fuks, Z
Leibel, S
Koutcher, JA
Citation: Cc. Ling et al., Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality, INT J RAD O, 47(3), 2000, pp. 551-560
Authors:
Potters, L
Cha, C
Oshinsky, G
Venkatraman, E
Zelefsky, M
Leibel, S
Citation: L. Potters et al., Risk profiles to predict PSA relapse-free survival for patients undergoingpermanent prostate brachytherapy, CA J SCI AM, 5(5), 1999, pp. 301-306
Authors:
Prados, MD
Scott, C
Curran, WJ
Nelson, DF
Leibel, S
Kramer, S
Citation: Md. Prados et al., Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplasticastrocytoma: A retrospective review of Radiation Therapy Oncology Group protocols comparing survival with carmustine or PCV adjuvant chemotherapy, J CL ONCOL, 17(11), 1999, pp. 3389-3395
Authors:
Cha, CM
Potters, L
Ashley, R
Freeman, K
Wang, XH
Waldbaum, R
Leibel, S
Citation: Cm. Cha et al., Isotope selection for patients undergoing prostate brachytherapy, INT J RAD O, 45(2), 1999, pp. 391-395
Authors:
Gelblum, DY
Potters, L
Ashley, R
Waldbaum, R
Wang, XH
Leibel, S
Citation: Dy. Gelblum et al., Urinary morbidity following ultrasound-guided transperineal prostate seed implantation, INT J RAD O, 45(1), 1999, pp. 59-67
Risultati:
1-10
|